Clinical Trial: Continuation of First-line Therapy with Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841172) titled 'Continuation of First-line Therapy with Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC' on Feb. 18.

Brief Summary: This multicenter, prospective, randomized, controlled, open-label, two-arm Phase III clinical trial is designed to evaluate whether adding radiotherapy to oligoprogressive lesions while continuing first-line systemic therapy at the time of oligoprogression can effectively prolong progression-free survival compared to early switching to second-line systemic therapy in oligoprogressive hepatocellular carcinoma.

Study Start Date: Feb. 24

Study Type: INTERVENTIONAL

Condition: OligoProgre...